Brief: Aroa Biosurgery Posts FY Product Gross Margin 85%
20/05/2024 23:49
May 21 (Reuters) - Aroa Biosurgery FY product gross margin 85%. * FY product revenue NZD 67.966 million * FY adjusted operating expenses NZD -68.127 million * FY adjusted EBIT NZD -7.49 million * FY adjusted pretax profit NZD -6.1 million * FY adjusted EBITDA NZD -3.095 million * FY gross profit NZD 58.973 million
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million